Comparison of substance use milestones in cannabis- and cocaine-dependent patients

Journal of Addictive Diseases

Volumn 31, Issue 1, 2012, Pages 60-66

  Horey, Jonathan T ^a,b   Mariani, John J ^a,b   Cheng, Wendy Y ^a,b   Bisaga, Adam ^a,b   Sullivan, Maria ^a,b   Nunes, Edward ^a,b   Levin, Frances R ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Cocaine dependence; Marijuana dependence; Substance abuse milestones

Indexed keywords

CANNABIS; COCAINE;

ADULT; AGE; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SUBSTANCE ABUSE;

ADULT; AGE OF ONSET; AMINES; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MARIJUANA ABUSE; TRIAZOLES; YOUNG ADULT;

EID: 84858113434     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.642753     Document Type: Article

References (27)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.
2. Bourdon KH, Rae DS, Locke BZ, Narrow WE, Regier DA. Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey. Public Health Rep 1992; 107(6):663-8.
3. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSMIV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6):617-27. (Pubitemid 40973437)
4. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51(1):8-19. (Pubitemid 24028993)
5. Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52(3):219-29.
6. von Sydow K, Lieb R, Pfister H, Hofler M, Sonntag H, Wittchen HU. The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend 2001; 64(3):347-61. (Pubitemid 32973878)
7. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67(2):247-57. (Pubitemid 43357471)
8. DeWit DJ, Adlaf EM, Offord DR, Ogborne AC. Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry 2000; 157(5):745-50. (Pubitemid 30249653)
9. Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcoholdependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004; 74(3):265-72. (Pubitemid 38759781)
10. Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A. Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 2005; 29(5):896-901. (Pubitemid 40686561)
11. Wagner FA, Anthony JC. Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Depend 2007; 86(2-3):191-8. (Pubitemid 44821600)
12. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002; 26(4):479-88. (Pubitemid 34260997)
13. Ridenour TA, Maldonado-Molina M, Compton WM, Spitznagel EL, Cottler LB. Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. Drug Alcohol Depend 2005; 80(1):1-14. (Pubitemid 41266957)
14. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994; 2(3):244-68.
15. O'Brien MS, Anthony JC. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 2005; 30(5):1006-18. (Pubitemid 40570915)
16. Kessler RC, Aguilar-Gaxiola S, Berglund PA, et al. Patterns and predictors of treatment seeking after onset of a substance use disorder. Arch Gen Psychiatry 2001; 58(11):1065-71. (Pubitemid 33051833)
17. Haas AL, Peters RH. Development of substance abuse problems among druginvolved offenders. Evidence for the telescoping effect. J Subst Abuse 2000; 12(3):241-53. (Pubitemid 38198169)
18. Ridenour TA, Lanza ST, Donny EC, Clark DB. Different lengths of times for progressions in adolescent substance involvement. Addict Behav 2006; 31(6):962-83. (Pubitemid 43775963)
19. Zinkernagel C, Naef MR, Bucher HC, Ladewig D, Gyr N, Battegay M. Onset and pattern of substance use in intravenous drug users of an opiate maintenance program. Drug Alcohol Depend 2001; 64(1):105-9. (Pubitemid 32695439)
20. Ridenour TA, Cottler LB, Compton WM, Spitznagel EL, Cunningham-Williams RM. Is there a progression from abuse disorders to dependence disorders? Addiction 2003; 98(5):635-44. (Pubitemid 36638202)
21. Hasin DS, Keyes KM, Alderson D, Wang S, Aharonovich E, Grant BF. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry. 2008; 69(9):1354-63.
22. McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction 2008; 103(7):1100-9. (Pubitemid 351832248)
23. ONDCP. Study Finds Highest Levels of THC in U.S. Marijuana to Date. Washington, DC: Office of National Drug Control Policy, 2007. Available at: http://www.whitehousedrugpolicy.gov/publications/news/press07/0425072.html.
24. ElSohly MA, Ross, SA, Mehmedic, Z, Arafat, R, Yi, B, Banahan BF III. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. J Forensic Sci 2000; 45(1):24-30. (Pubitemid 30041605)
25. King LA, Carpentier C, Griffiths P. Cannabis potency in Europe. Addiction 2005; 100(7):884-6. (Pubitemid 40897273)
26. Smith N. High potency cannabis: the forgotten variable. Addiction 2005; 100(10):1558-60.
27. Van Etten ML, Anthony JC. Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Depend 1999; 54(2):117-25. (Pubitemid 29114990)